Related Experiment Video
Updated: Jul 27, 2025

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Huntington's Disease with Small CAG Repeat Expansions
Anna Heinzmann1,2, Sabrina Sayah2, François-Xavier Lejeune1,3
1Sorbonne Université, Paris Brain Institute (ICM Institut du Cerveau), APHP, INSERM, CRNS, Paris, France.
Individuals with small CAG repeat expansions (36-38) in the HTT gene show similar cognitive function to those with typical Huntington's disease expansions (40-42). However, they often present with fewer motor symptoms, potentially delaying diagnosis.
Area of Science:
- Genetics
- Neuroscience
- Neurology
Background:
- Small cytosine-adenine-guanine (CAG) repeat expansions (36-38) in the HTT gene are traditionally linked to milder Huntington's disease (HD).
- The clinical presentation and detailed phenotype of these individuals remain understudied.
- Understanding their profile is crucial for accurate diagnosis and genetic counseling.
Purpose of the Study:
- To investigate the clinical and neuropsychological phenotype of individuals carrying CAG36-38 repeat expansions in the HTT gene.
- To compare the characteristics of CAG36-38 carriers with those of CAG40-42 carriers.
- To elucidate factors contributing to diagnostic delays in this subgroup.
Main Methods:
- Inclusion of 35 patients and premanifest carriers with CAG36-38 repeats.
- Comparative analysis of clinical and neuropsychological data between 11 CAG36-38 patients and 11 matched CAG40-42 patients.
- Utilizing data from 243 CAG36-38 individuals from the ENROLL study for comprehensive phenotype description.
Main Results:
- Similar global cognitive efficiency and subdomain performance were observed between CAG36-38 and CAG40-42 carriers.
- Chorea was a significantly less frequent initial symptom in CAG36-38 patients, despite comparable motor scores at initial assessment.
- CAG36-38 carriers exhibited significantly lower total motor scores at the last visit.
- Clinicians showed reduced confidence in diagnosing HD in CAG36-38 carriers, leading to significantly later diagnoses despite similar ages at symptom onset.
- Confirmation of similar cognitive and distinct motor profiles in larger cohorts (CAG36-38: n=243; CAG40-42: n=4675) from the ENROLL database.
Conclusions:
- Small CAG36-38 expansions in the HTT gene are associated with a cognitive profile similar to, but a distinct motor profile from, more common CAG40-42 expansions.
- Absence of chorea, rather than low symptom penetrance, may contribute to delayed molecular diagnosis in CAG36-38 carriers.
- Neurologists should consider HD in elderly patients with cognitive impairment but without typical chorea, with implications for genetic counseling of offspring.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Genetic Lingo
Lysosomal Hydrolases
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

